Adaptive Biotechnologies Corp(ADPT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ADPT Adaptive Biotechnologies Corp

休市中 09-19 16:00:00 EDT

13.36

-0.41

-2.98%

盘后13.42

+0.06+0.45%

19:15 EDT

最高13.90	最低13.26	成交量262.84万
今开13.87	昨收13.77	日振幅4.68%
总市值20.34亿	流通市值15.68亿	总股本1.52亿
成交额3,545万	换手率2.24%	流通股本1.17亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ADPT","market":"US","secType":"STK","nameCN":"Adaptive Biotechnologies Corp","latestPrice":13.36,"timestamp":1758312000000,"preClose":13.77,"halted":0,"volume":2628359,"hourTrading":{"tag":"盘后","latestPrice":13.42,"preClose":13.36,"latestTime":"19:15 EDT","volume":318669,"amount":4257710.195,"timestamp":1758323720897},"delay":0,"floatShares":117369033,"shares":152273915,"eps":-0.812937,"marketStatus":"休市中","change":-0.41,"latestTime":"09-19 16:00:00 EDT","open":13.87,"high":13.9,"low":13.255,"amount":35449279.727211,"amplitude":0.046841,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.812937,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1758528000000},"marketStatusCode":7,"adr":0,"listingDate":1561608000000,"exchange":"NASDAQ","adjPreClose":13.77,"preHourTrading":{"tag":"盘前","latestPrice":14.09,"preClose":13.77,"latestTime":"09:09 EDT","volume":185,"amount":2584.08999,"timestamp":1758287360277},"postHourTrading":{"tag":"盘后","latestPrice":13.42,"preClose":13.36,"latestTime":"19:15 EDT","volume":318669,"amount":4257710.195,"timestamp":1758323720897},"volumeRatio":1.680908308263029,"impliedVol":0.7214,"impliedVolPercentile":0.228},"requestUrl":"/m/hq/s/ADPT","defaultTab":"news","newsList":[{"id":"2559098496","title":"Adaptive Biotechnologies Corporation盘中异动 大幅拉升5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2559098496","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559098496?lang=zh_cn&edition=full","pubTime":"2025-08-13 23:27","pubTimestamp":1755098872,"startTime":"0","endTime":"0","summary":"北京时间2025年08月13日23时27分，Adaptive Biotechnologies Corporation股票出现异动，股价急速上涨5.06%。Adaptive Biotechnologies Corporation股票所在的生物技术行业中，整体涨幅为1.10%。Adaptive Biotechnologies Corporation公司简介：Adaptive Biotechnologies Corp 是一家通过利用适应性免疫系统的固有生物学来改变疾病的诊断和治疗，来推进免疫驱动医学领域的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250813232752a486a386&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","ADPT"],"gpt_icon":0},{"id":"2558681269","title":"Adaptive Biotechnologies Corporation2025财年第二财季实现净利润-25.61百万美元，同比增加44.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558681269","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558681269?lang=zh_cn&edition=full","pubTime":"2025-08-11 00:01","pubTimestamp":1754841706,"startTime":"0","endTime":"0","summary":"8月11日，Adaptive Biotechnologies Corporation公布财报，公告显示公司2025财年第二财季净利润为-25.61百万美元，同比增加44.59%；其中营业收入为58.88百万美元，同比增加36.33%，每股基本收益为-0.17美元。从资产负债表来看，Adaptive Biotechnologies Corporation总负债3.17亿美元，其中短期债务13.03百万美元，资产负债比为1.57，流动比率为0.03。机构评级：截至2025年8月11日，当前有6家机构对Adaptive Biotechnologies Corporation目标价做出预测，其中目标均价为14.00美元，其中最低目标价为11.00美元，最高目标价为15.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811000413a6de0857&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADPT"],"gpt_icon":0},{"id":"2557156043","title":"Adaptive Biotechnologies Corporation盘中异动 股价大涨5.05%报12.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557156043","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557156043?lang=zh_cn&edition=full","pubTime":"2025-08-08 00:44","pubTimestamp":1754585073,"startTime":"0","endTime":"0","summary":"北京时间2025年08月08日00时44分，Adaptive Biotechnologies Corporation股票出现波动，股价快速拉升5.05%。截至发稿，该股报12.28美元/股，成交量159.537万股，换手率1.05%，振幅7.44%。Adaptive Biotechnologies Corporation股票所在的生物技术行业中，整体涨幅为0.11%。Adaptive Biotechnologies Corporation公司简介：Adaptive Biotechnologies Corp 是一家通过利用适应性免疫系统的固有生物学来改变疾病的诊断和治疗，来推进免疫驱动医学领域的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508080044339739fae3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADPT","BK4121"],"gpt_icon":0},{"id":"2557705523","title":"Adaptive Biotechnologies Corporation盘中异动 早盘股价大涨15.70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557705523","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557705523?lang=zh_cn&edition=full","pubTime":"2025-08-06 21:31","pubTimestamp":1754487085,"startTime":"0","endTime":"0","summary":"北京时间2025年08月06日21时31分，Adaptive Biotechnologies Corporation股票出现波动，股价快速上涨15.70%。截至发稿，该股报12.79美元/股，成交量11.1304万股，换手率0.07%，振幅5.66%。Adaptive Biotechnologies Corporation股票所在的生物技术行业中，整体跌幅为0.06%。Adaptive Biotechnologies Corporation公司简介：Adaptive Biotechnologies Corp 是一家通过利用适应性免疫系统的固有生物学来改变疾病的诊断和治疗，来推进免疫驱动医学领域的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806213125a478d7d6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","ADPT"],"gpt_icon":0},{"id":"1115050403","title":"异动解读 | 业绩超预期，Adaptive Biotechnologies盘后大涨10.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=1115050403","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1115050403?lang=zh_cn&edition=full","pubTime":"2025-08-06 05:06","pubTimestamp":1754427995,"startTime":"0","endTime":"0","summary":"生物技术公司Adaptive Biotechnologies Corp今日盘后股价大涨10.32%，引起投资者广泛关注。这一显著涨幅主要源于公司发布的最新季度财报优于市场预期。根据公司公布的财报，截至6月30日的季度中，Adaptive Biotechnologies的调整后每股亏损为0.17美元，明显好于分析师平均预期的0.24美元亏损。值得注意的是，尽管公司仍处于亏损状态，但亏损幅度较去年同期的每股0.31美元有明显收窄。这些积极因素综合推动了投资者信心，促使股价在盘后交易中大幅上涨。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ADPT"],"gpt_icon":0},{"id":"2557831180","title":"Adaptive Biotechnologies Q2 EPS $(0.17) Beats $(0.24) Estimate, Sales $58.879M Beat $49.400M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2557831180","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557831180?lang=zh_cn&edition=full","pubTime":"2025-08-06 04:06","pubTimestamp":1754424388,"startTime":"0","endTime":"0","summary":"Adaptive Biotechnologies (NASDAQ:ADPT) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.24) by 30.33 percent. This is a 45.16 percent increase over losses of $(0.31) per","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"Adaptive Biotechnologies第二季度每股收益(0.17)美元超出预期(0.24)美元，销售额5887.9万美元超出预期4940万美元","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/08/46871204/adaptive-biotechnologies-q2-eps-0-17-beats-0-24-estimate-sales-58-879m-beat-49-400m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Adaptive Biotechnologies Q2 EPS $(0.17) Beats $(0.24) Estimate, Sales $58.879M Beat $49.400M Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADPT"],"gpt_icon":0},{"id":"2557633648","title":"Adaptive Biotechnologies Corporation盘中异动 下午盘股价大涨5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557633648","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557633648?lang=zh_cn&edition=full","pubTime":"2025-08-05 03:16","pubTimestamp":1754335018,"startTime":"0","endTime":"0","summary":"北京时间2025年08月05日03时16分，Adaptive Biotechnologies Corporation股票出现波动，股价大幅拉升5.13%。Adaptive Biotechnologies Corporation股票所在的生物技术行业中，整体涨幅为1.52%。Adaptive Biotechnologies Corporation公司简介：Adaptive Biotechnologies Corp 是一家通过利用适应性免疫系统的固有生物学来改变疾病的诊断和治疗，来推进免疫驱动医学领域的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080503165994cf7b61&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADPT","BK4121"],"gpt_icon":0},{"id":"2548881323","title":"Adaptive Biotechnologies Corporation盘中异动 股价大涨5.00%报11.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548881323","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548881323?lang=zh_cn&edition=full","pubTime":"2025-07-02 22:39","pubTimestamp":1751467179,"startTime":"0","endTime":"0","summary":"北京时间2025年07月02日22时39分，Adaptive Biotechnologies Corporation股票出现异动，股价急速拉升5.00%。截至发稿，该股报11.75美元/股，成交量32.2286万股，换手率0.21%，振幅4.56%。Adaptive Biotechnologies Corporation股票所在的生物技术行业中，整体涨幅为0.74%。Adaptive Biotechnologies Corporation公司简介：Adaptive Biotechnologies Corp 是一家通过利用适应性免疫系统的固有生物学来改变疾病的诊断和治疗，来推进免疫驱动医学领域的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070222394097976712&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","ADPT"],"gpt_icon":0},{"id":"2546249826","title":"Adaptive Biotechnologies Corporation盘中异动 早盘快速上涨5.16%报11.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546249826","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546249826?lang=zh_cn&edition=full","pubTime":"2025-06-25 22:20","pubTimestamp":1750861226,"startTime":"0","endTime":"0","summary":"北京时间2025年06月25日22时20分，Adaptive Biotechnologies Corporation股票出现波动，股价急速上涨5.16%。截至发稿，该股报11.20美元/股，成交量88.9599万股，换手率0.59%，振幅5.31%。Adaptive Biotechnologies Corporation股票所在的生物技术行业中，整体跌幅为0.83%。Adaptive Biotechnologies Corporation公司简介：Adaptive Biotechnologies Corp 是一家通过利用适应性免疫系统的固有生物学来改变疾病的诊断和治疗，来推进免疫驱动医学领域的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625222027952b490b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADPT","BK4121"],"gpt_icon":0},{"id":"2544905483","title":"Adaptive Biotechnologies Corporation盘中异动 大幅拉升5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2544905483","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544905483?lang=zh_cn&edition=full","pubTime":"2025-06-18 22:30","pubTimestamp":1750257005,"startTime":"0","endTime":"0","summary":"北京时间2025年06月18日22时30分，Adaptive Biotechnologies Corporation股票出现波动，股价急速拉升5.08%。Adaptive Biotechnologies Corporation股票所在的生物技术行业中，整体涨幅为0.78%。Adaptive Biotechnologies Corporation公司简介：Adaptive Biotechnologies Corp 是一家通过利用适应性免疫系统的固有生物学来改变疾病的诊断和治疗，来推进免疫驱动医学领域的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250618223005a710ac2c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","ADPT"],"gpt_icon":0},{"id":"2544971184","title":"Craig-Hallum Initiates Adaptive Biotechnologies at Buy With $15 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2544971184","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544971184?lang=zh_cn&edition=full","pubTime":"2025-06-18 19:24","pubTimestamp":1750245881,"startTime":"0","endTime":"0","summary":"Adaptive Biotechnologies (ADPT) has an average rating of buy and mean price target of $11.86, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"Craig-Hallum给予Adaptive Biotechnologies买入评级，目标价15美元","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ADPT"],"gpt_icon":0},{"id":"2541869818","title":"Adaptive Biotechnologies Corporation盘中异动 股价大涨5.07%报10.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2541869818","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541869818?lang=zh_cn&edition=full","pubTime":"2025-06-06 22:53","pubTimestamp":1749221637,"startTime":"0","endTime":"0","summary":"北京时间2025年06月06日22时53分，Adaptive Biotechnologies Corporation股票出现异动，股价急速上涨5.07%。截至发稿，该股报10.37美元/股，成交量27.5018万股，换手率0.18%，振幅4.33%。Adaptive Biotechnologies Corporation股票所在的生物技术行业中，整体涨幅为0.44%。Adaptive Biotechnologies Corporation公司简介：Adaptive Biotechnologies Corp 是一家通过利用适应性免疫系统的固有生物学来改变疾病的诊断和治疗，来推进免疫驱动医学领域的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250606225357a6fd5b5f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","ADPT"],"gpt_icon":0},{"id":"2539619112","title":"Adaptive Biotechnologies Corporation盘中异动 早盘急速上涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2539619112","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539619112?lang=zh_cn&edition=full","pubTime":"2025-05-29 22:52","pubTimestamp":1748530366,"startTime":"0","endTime":"0","summary":"北京时间2025年05月29日22时52分，Adaptive Biotechnologies Corporation股票出现异动，股价快速上涨5.14%。Adaptive Biotechnologies Corporation股票所在的生物技术行业中，整体涨幅为0.72%。Adaptive Biotechnologies Corporation公司简介：Adaptive Biotechnologies Corp 是一家通过利用适应性免疫系统的固有生物学来改变疾病的诊断和治疗，来推进免疫驱动医学领域的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250529225246a491814c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADPT","BK4121"],"gpt_icon":0},{"id":"2533654158","title":"Piper Sandler：维持Adaptive Biotechnologies(ADPT.US)评级，由增持调整至增持评级, 目标价由11.00美元调整至13.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2533654158","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533654158?lang=zh_cn&edition=full","pubTime":"2025-05-07 00:11","pubTimestamp":1746547903,"startTime":"0","endTime":"0","summary":"Piper Sandler：维持Adaptive Biotechnologies(ADPT.US)评级，由增持调整至增持评级, 目标价由11.00美元调整至13.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/07001150176756.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ADPT"],"gpt_icon":0},{"id":"2532822259","title":"高盛：维持Adaptive Biotechnologies(ADPT.US)评级，由买入调整至买入评级, 目标价由9.00美元调整至10.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2532822259","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532822259?lang=zh_cn&edition=full","pubTime":"2025-05-03 00:52","pubTimestamp":1746204727,"startTime":"0","endTime":"0","summary":"高盛：维持Adaptive Biotechnologies(ADPT.US)评级，由买入调整至买入评级, 目标价由9.00美元调整至10.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/03005250110078.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ADPT"],"gpt_icon":0},{"id":"2532682264","title":"Adaptive Biotechnologies Shares Surge After Q1 Loss Narrows, Revenue Rises","url":"https://stock-news.laohu8.com/highlight/detail?id=2532682264","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532682264?lang=zh_cn&edition=full","pubTime":"2025-05-03 00:35","pubTimestamp":1746203754,"startTime":"0","endTime":"0","summary":"Adaptive Biotechnologies  shares surged nearly 37% in recent Friday trading, a day after the company reported a narrower loss and higher revenue in Q1.The company reported a Q1 diluted loss late Thursday of $0.20 per share, narrowing from a loss of $0.33 a year earlier.Analysts polled by FactSet expected a loss of $0.29.Revenue for the quarter ended March 31 was $52.4 million, up from $41.9 million a year earlier.Analysts surveyed by FactSet expected $42.7 million.The company raised its full-year revenue guidance for the Minimal Residual Disease business to $180 million to $190 million from $175 million to $185 million previously. The company did not provide revenue guidance for its Immune Medicine business.Analysts surveyed by FactSet expect total revenue of $216 million for the year.The company also said it now expects full-year total company cash burn at $50 million to $60 million, versus $60 million to $70 million previously.Price: 10.06, Change: +2.70, Percent Change: +36.71","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"第一季度亏损收窄、收入增长后，Adaptive Biotechnologies股价飙升","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ADPT"],"gpt_icon":0},{"id":"1118235387","title":"异动解读 | 业绩超预期,Adaptive Biotechnologies盘中大涨32.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=1118235387","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1118235387?lang=zh_cn&edition=full","pubTime":"2025-05-02 21:45","pubTimestamp":1746193518,"startTime":"0","endTime":"0","summary":"生物技术公司Adaptive Biotechnologies Corp今日盘中股价大涨32.01%，引起投资者广泛关注。这一显著涨幅主要源于公司发布的2025年第一季度财报远超华尔街预期。根据公司公布的财报，截至2025年3月31日的季度中，Adaptive Biotechnologies调整后每股亏损为0.20美元，明显优于分析师平均预期的0.29美元亏损。值得注意的是，尽管当季仍录得2985万美元亏损，但Adaptive Biotechnologies的业绩已连续数个季度超出预期。这一业绩改善和乐观前景推动了公司股价的强劲表现，也反映出投资者对Adaptive Biotechnologies未来发展的信心增强。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ADPT"],"gpt_icon":0},{"id":"2532539844","title":"Adaptive Biotechnologies Corporation盘中异动 快速上涨18.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2532539844","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532539844?lang=zh_cn&edition=full","pubTime":"2025-05-02 21:31","pubTimestamp":1746192671,"startTime":"0","endTime":"0","summary":"北京时间2025年05月02日21时31分，Adaptive Biotechnologies Corporation股票出现波动，股价大幅拉升18.89%。Adaptive Biotechnologies Corporation股票所在的生物技术行业中，整体涨幅为1.23%。其相关个股中，Polyrizon Ltd.、Impact Biomedical, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Pmgc Holdings Inc.、Polyrizon Ltd.、Adial Pharmaceuticals, Inc较为活跃，换手率分别为199.08%、138.47%、52.84%，振幅较大的相关个股有Polyrizon Ltd.、Onconetix, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 ，振幅分别为8.72%、8.45%、8.04%。Adaptive Biotechnologies Corporation公司简介：Adaptive Biotechnologies Corp 是一家通过利用适应性免疫系统的固有生物学来改变疾病的诊断和治疗，来推进免疫驱动医学领域的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502213111a6d11c91&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADPT","BK4121"],"gpt_icon":0},{"id":"1184587265","title":"异动解读 | 突破预期！Adaptive Biotechnologies一季度业绩亮眼，盘前大涨11.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=1184587265","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1184587265?lang=zh_cn&edition=full","pubTime":"2025-05-02 20:03","pubTimestamp":1746187436,"startTime":"0","endTime":"0","summary":"周五盘前，Adaptive Biotechnologies Corp股价大涨11.41%，投资者对公司最新发布的第一季度财报反应积极。根据公司公布的财报，截至2025年3月31日的第一季度，Adaptive Biotechnologies调整后每股亏损为0.20美元，明显优于分析师平均预期的0.29美元亏损。分析师对Adaptive Biotechnologies保持乐观态度，目前平均评级为\"买入\"，其中7个为\"强烈买入\"或\"买入\"，1个为\"持有\"，没有\"卖出\"或\"强烈卖出\"评级。值得注意的是，Adaptive Biotechnologies今年以来的股价已上涨22.8%，显示出投资者对公司前景的信心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ADPT"],"gpt_icon":0},{"id":"1105607538","title":"异动解读 | 业绩超预期，Adaptive Biotechnologies盘前大涨11.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=1105607538","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1105607538?lang=zh_cn&edition=full","pubTime":"2025-05-02 20:03","pubTimestamp":1746187431,"startTime":"0","endTime":"0","summary":"生物技术公司Adaptive Biotechnologies Corp今日盘前股价大涨11.41%，引起投资者广泛关注。这一显著涨幅主要源于公司发布的2025年第一季度财报远超华尔街预期。根据公司公布的财报，截至2025年3月31日的季度中，Adaptive Biotechnologies调整后每股亏损为0.20美元，明显优于分析师平均预期的0.29美元亏损。值得注意的是，尽管当季仍录得2985万美元亏损，但Adaptive Biotechnologies的业绩已连续数个季度超出预期。分析师普遍对公司持积极态度，平均评级为\"买入\"，12个月目标价中位数为10.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | 业绩超预期，Adaptive Biotechnologies盘前大涨11.41%","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ADPT"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.adaptivebiotech.com","stockEarnings":[{"period":"1week","weight":0.0595},{"period":"1month","weight":0.0866},{"period":"3month","weight":0.2871},{"period":"6month","weight":0.5905},{"period":"1year","weight":1.795},{"period":"ytd","weight":1.2285}],"compareEarnings":[{"period":"1week","weight":0.0096},{"period":"1month","weight":0.0401},{"period":"3month","weight":0.1168},{"period":"6month","weight":0.1768},{"period":"1year","weight":0.1624},{"period":"ytd","weight":0.1324}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Adaptive Biotechnologies Corporation于2009年9月8日在华盛顿州注册成立。公司正通过利用适应性免疫系统的固有生物学，向疾病的诊断和治疗转变，推进免疫驱动医学领域。该公司认为，适应性免疫系统是大自然对大多数疾病进行的最精细的诊断和治疗，但无法解码使医学界无法充分利用其能力。该公司的免疫医学平台应用专有技术来读取患者免疫系统的多种遗传密码，并准确了解如何检测和治疗该患者的疾病。该公司的免疫医学平台应用专有技术来读取患者免疫系统的多种遗传密码，并准确了解如何检测和治疗该患者的疾病。该公司在动态临床免疫组学数据库中捕捉到这些见解，该数据库以计算生物学和机器学习为基础，用于开发和商业化公司正在为每位患者量身定制的临床产品和服务。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.030966},{"month":2,"riseRate":0.5,"avgChangeRate":-0.017515},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.104089},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.10078},{"month":5,"riseRate":0.5,"avgChangeRate":0.108472},{"month":6,"riseRate":0.833333,"avgChangeRate":0.100403},{"month":7,"riseRate":0.428571,"avgChangeRate":-0.001043},{"month":8,"riseRate":0.571429,"avgChangeRate":0.074393},{"month":9,"riseRate":0.428571,"avgChangeRate":-0.083075},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.062214},{"month":11,"riseRate":0.666667,"avgChangeRate":0.035467},{"month":12,"riseRate":0.833333,"avgChangeRate":0.066718}],"exchange":"NASDAQ","name":"Adaptive Biotechnologies Corp","nameEN":"Adaptive Biotechnologies Corp"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.3","shortVersion":"4.35.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Adaptive Biotechnologies Corp(ADPT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Adaptive Biotechnologies Corp(ADPT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Adaptive Biotechnologies Corp,ADPT,Adaptive Biotechnologies Corp股票,Adaptive Biotechnologies Corp股票老虎,Adaptive Biotechnologies Corp股票老虎国际,Adaptive Biotechnologies Corp行情,Adaptive Biotechnologies Corp股票行情,Adaptive Biotechnologies Corp股价,Adaptive Biotechnologies Corp股市,Adaptive Biotechnologies Corp股票价格,Adaptive Biotechnologies Corp股票交易,Adaptive Biotechnologies Corp股票购买,Adaptive Biotechnologies Corp股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Adaptive Biotechnologies Corp(ADPT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Adaptive Biotechnologies Corp(ADPT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}